Gate2Brain
Develops a brain tumour therapeutic candidate, with recent funding to support advancement of the program from its Barcelona base.
Overview
Gate2Brain is a Barcelona-based company focused on advancing a brain tumour candidate. The available funding disclosure positions the business in therapeutic development rather than AI software, with its target market centered on oncology and brain tumour treatment. The company secured €7 million in an undisclosed round announced in June 2026. The financing is intended to advance its brain tumour candidate, giving Gate2Brain fresh capital to support development of its disclosed program.
Funding History
Barcelona-based Gate2Brain secures €7 million to advance brain tumour candidate
Frequently Asked Questions
- How much funding does AI Funding track for Gate2Brain?
- AI Funding tracks €7M for Gate2Brain across 1 funding round in this database.
- Who are Gate2Brain's investors?
- Gate2Brain's investors include Shilpa Biocare Pvt Ltd.
- What does Gate2Brain do?
- Gate2Brain is a Barcelona-based company focused on advancing a brain tumour candidate. The available funding disclosure positions the business in therapeutic development rather than AI software, with its target market centered on oncology and brain tumour treatment. The company secured €7 million in an undisclosed round announced in June 2026. The financing is intended to advance its brain tumour candidate, giving Gate2Brain fresh capital to support development of its disclosed program.
- Where is Gate2Brain headquartered?
- Gate2Brain is headquartered in Barcelona, Spain.
Related Insights
Compare the leading AI-focused VC firms: Andreessen Horowitz, Sequoia Capital, Thrive Capital, and 7 more. Analysis of 150+ AI deals, investment strategies, sector focus, and portfolio performance.
Track 395+ AI funding rounds—investors, valuations, and deal sizes from pre-seed to IPO. Updated daily so you never miss a round.
An in-depth look at how AI-focused venture capital operates — from fund structure and deal sourcing to due diligence, portfolio management, and exit strategies in the AI era.